Riskpilot← Back to searchSign inGet full accessNEMUS NYDALEN AS
ASActiveOrg 927917238Nydalsveien 15, 0484 OsloTraditional, complementary and alternative medicine activities · NACE 8696Est. 20210 employeesdhn.no
Revenue 2024
NOK 7,4M
-4% vs 2023
EBITDA margin
4.5%
+46% vs 2023
Equity ratio
43.2%
Financial strength
Net profit 2024
NOK 174K
+61% vs 2023
| Revenue | NOK 7,4M | -4% |
| EBITDA | NOK 336K | +46% |
| Net profit | NOK 174K | +61% |
| Total assets | NOK 1,1M | -12% |
| Equity | NOK 490K | +55% |
| Employees | 0 | — |
Legal name
NEMUS NYDALEN AS
Org number
927917238
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
12. oktober 2021
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og ett styremedlem i fellesskap.
Company purpose
Kiropraktorvirksomhet og andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Nydalsveien 15, 0484 Oslo
Website
dhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 7 630 | 7 724 | 7 395 |
| Staff expenses | −0 | −0 | −10 | −21 |
| EBITDA | −75 | 314 | 231 | 336 |
| Depreciation & amort. | −0 | −85 | −89 | −93 |
| EBIT | −75 | 229 | 141 | 243 |
| Net financials | −6 | −2 | −1 | −2 |
| Profit before tax | −81 | 227 | 140 | 242 |
| Tax | −0 | 50 | 32 | 67 |
| Net profit | −81 | 177 | 108 | 174 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 410 | 1 206 | 1 291 | 1 135 |
| Equity | 30 | 207 | 316 | 490 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 380 | 998 | 976 | 645 |
| Total debt | 380 | 998 | 976 | 645 |
EBITDA margin
4.5%
This company
15.8%
Market median
-72% vs market
20212024
Equity ratio
43.2%
This company
38.2%
Market median
+13% vs market
20212024
Return on equity
35.6%
This company
18.4%
Market median
+93% vs market
20212024
Net profit margin
2.4%
This company
8.1%
Market median
-70% vs market
20212024
Asset turnover
6.51×
This company
1.12×
Market median
+481% vs market
20212024
Debt / equity
1.32×
This company
0.62×
Market median
-113% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Chairman | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 | |
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lillegrims Knekk & Brekk As
NEMUS NYDALEN AS Board members of NEMUS NYDALEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Toralf Wollkert-Thomassen | Chairman | 0 companies |
| Linda Katarina Wollkert | Board of Directors | 0 companies |
| Martin Grimsrud | Board of Directors | 0 companies |
| Toralf Thomassen | Chairman | 0 companies |